{
    "organizations": [],
    "uuid": "51aaf0b4519a50ddac5311481a2d02eb72d08f5f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncology-venture-to-execute-the-tk/brief-oncology-venture-to-execute-the-tki-license-idUSFWN1PA0D0",
    "ord_in_thread": 0,
    "title": "BRIEF-Oncology Venture To Execute The TKI License",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 15 (Reuters) - ONCOLOGY VENTURE SWEDEN AB:\n* ONCOLOGY VENTURE WILL EXECUTE LICENSE TO MULTI TKI PHASE 3 COMPOUND\n* ‍NO FURTHER DETAILS HAVE BEEN DISCLOSED ON FINANCIAL CONTENT OF DEAL​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-15T21:49:00.000+02:00",
    "crawled": "2018-01-16T13:29:18.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "oncology",
        "venture",
        "sweden",
        "ab",
        "oncology",
        "venture",
        "execute",
        "license",
        "multi",
        "tki",
        "phase",
        "compound",
        "detail",
        "disclosed",
        "financial",
        "content",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}